The South America cardiac arrhythmia monitoring devices market size is projected to expand at a CAGR of 5.1 % during the forecast period, 2021-2028. The growth of the market is attributed to the increased requirement for sturdy and high-quality products in the healthcare sector.
Cardiac monitoring is not essential but is required continuously for cardiac arrhythmia. As cardiac arrhythmia is not curable, it’s not practical to retain a patient in the hospital for extremely long duration period, and nor it’s practical to ask a patient to visit the hospital every day. Thus, the preferred way to continuously monitor the patients suffering from cardiac arrhythmia is through remote patient monitoring by using the cardiac arrhythmia monitoring devices.
The report on the South America cardiac arrhythmia monitoring devices market includes an assessment of the market, trends, segments and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Cardiac Arrhythmia Monitoring Devices Market - South America Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Devices (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, Holter Monitoring Devices, Other Devices) and Service Providers (Mobile Cardiac Telemetry Monitoring Service Providers, Independent Diagnostic Testing Facilities/Clinics) |
Geographical Scope |
Brazil, Argentina, and Rest of South America |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Abbott Laboratories, GE Healthcare, Medtronic PLC, Boston Scientific Corporation, and Koninklijke Philips Nv |
Based on devices, the market is segregated as event monitoring devices, continuous rhythm monitoring devices, holter monitoring devices, and others. The holter monitoring devices segment is expected to dominate the market during the forecast period. This type of device is used for diagnosing sporadic symptoms in patients. It also offers faster and convenient monitoring to increase patient compliance and is expected to enhance the treatment outcome. On the other hand, the continuous rhythm monitoring devices is expected to grow at a steady rate during the forecast period.
On the basis of service providers, the market is divided into mobile cardiac telemetry monitoring service providers and independent diagnostic testing facilities/clinics. The mobile cardiac telemetry monitoring service providers segment is projected to account for a large market share during the forecast period. Conversely, the latter segment is expected to grow at a substantial rate in the projected timeline. This is due to rising awareness about the disease and increasing screening in emerging economies.
In terms of geography the market is classified as Brazil, Argentina, and Rest of South America. The market in Brazil is projected to exhibit a high CAGR during the forecast period owing to the increasing demand for cardiac arrhythmia monitoring devices to rising cases of cardiac arrhythmia in the country. Rising improvement in the healthcare scenario is boosting the growth of the market in Brazil.
Some of the major players in the market are Abbott Laboratories, GE Healthcare, Medtronic PLC, Boston Scientific Corporation, koninklijke philips nv.
The majority of the cardiac arrhythmia monitoring devices are being manufactured by the global key players. Companies are engaging in partnerships, acquisitions, and mergers to expand their market share.
Some other reports from this category!